7/18/2024
Practice Questions—Bone, Urologic,
Ear and Eye Drugs, Lifespan
Prescribing, Principles of
1
Pharmacology & Prescribing Basics
Patti Parker, PhD, RN, AGNP, BC
NURS 5334 Advanced Pharmacology Quiz 1
Questions
1
and Answers Latest 2026/27- UTA1
2
Metabolic Bone Review Cases/Questions
2
1
, 7/18/2024
3 Question One
45-year-old African American woman who was a
previous smoker has a BMI of 32 kg/m2. She is currently
on a 1-week taper of Prednisone for an asthma flair.
She is also taking Lisinopril 20 mg for HTN. Which of the
following is associated with the most INCREASED risk for
her developing osteoporosis in this patient?
a. AA ethnicity
b. Past smoker
c. Present use of steroids
d. Female gender
e. BMI > 30 kg/m2 bigger u are less risk
3
4 Question One
45-year-old African American woman who was a
previous smoker has a BMI of 32 kg/m2. She is currently
on a 1-week taper of Prednisone for an asthma flair.
She is also taking Lisinopril 20 mg for HTN. Which of the
following is associated with the most INCREASED risk for
her developing osteoporosis in this patient?
a. AA ethnicity
b. Past smoker
c. Present use of steroids
d. Female gender
e. BMI > 30 kg/m2
4
2
, 7/18/2024
5 Question Two alendronate is prototype biphosphanate
72 y/o woman with a history of vertebral
compression fracture and a DEXA T score of -2.7 in
the left hip. What is the best initial therapy for this
patient?
A. Fosamax [Alendronate] 70 mg weekly
B. Calcitonin [1] spray to alternating nares qd
C. Prempro [estrogen / progestin] 0.625/2.5 mg [1] qd
D. Prolia [Denosumab] 60 mg SQ every 6 months
5
6 Question Two
72 y/o woman with a history of vertebral
compression fracture and a DEXA T score of -2.7 in
the left hip. What is the best initial therapy for this
patient?
A. Fosamax [Alendronate] 70 mg weekly
B. Calcitonin [1] spray to alternating nares qd
C. Prempro [estrogen / progestin] 0.625/2.5 mg [1] qd
D. Prolia [Denosumab] 60 mg SQ every 6 months
6
3
, 7/18/2024
Type text here
7 Question Three
75 y/o woman with newly diagnosed osteoporosis, being
discharged after total hip replacement due to right hip
fracture. She has never been medication for
osteoporosis. PMH is significant for severe GERD, DVT [20
years ago], atrial fibrillation and family history of breast
cancer. Which therapy may offer the MOST benefit in
this patient?
A. Prolia [Denosumab] 60 mg SQ every 6 months
B. Calcitonin [1] spray to alternative nares qd
dvt knocks this out C. Evista [Raloxifene] 60 mg daily
use forteo to stimulate
D. blast - very severe
Forteo disease20 mcg SC daily
[Teriparatide]
E. Reclast [Zoledronic acid] 5 mg IV every 12 months cont with afib
7
8 Question Three
75 y/o woman with newly diagnosed osteoporosis, being
discharged after total hip replacement due to right hip
fracture. She has never been medication for
osteoporosis. PMH is significant for severe GERD, DVT [20
years ago], atrial fibrillation and family history of breast
cancer. Which therapy may offer the MOST benefit in this
patient?
A. Prolia [Denosumab] 60 mg SQ every 6 months
B. Calcitonin [1] spray to alternative nares qd
C. Evista [Raloxifene] 60 mg daily
D. Forteo [Teriparatide] 20 mcg SC daily
E. Reclast [Zoledronic acid] 5 mg IV every 12 months
8
4
Practice Questions—Bone, Urologic,
Ear and Eye Drugs, Lifespan
Prescribing, Principles of
1
Pharmacology & Prescribing Basics
Patti Parker, PhD, RN, AGNP, BC
NURS 5334 Advanced Pharmacology Quiz 1
Questions
1
and Answers Latest 2026/27- UTA1
2
Metabolic Bone Review Cases/Questions
2
1
, 7/18/2024
3 Question One
45-year-old African American woman who was a
previous smoker has a BMI of 32 kg/m2. She is currently
on a 1-week taper of Prednisone for an asthma flair.
She is also taking Lisinopril 20 mg for HTN. Which of the
following is associated with the most INCREASED risk for
her developing osteoporosis in this patient?
a. AA ethnicity
b. Past smoker
c. Present use of steroids
d. Female gender
e. BMI > 30 kg/m2 bigger u are less risk
3
4 Question One
45-year-old African American woman who was a
previous smoker has a BMI of 32 kg/m2. She is currently
on a 1-week taper of Prednisone for an asthma flair.
She is also taking Lisinopril 20 mg for HTN. Which of the
following is associated with the most INCREASED risk for
her developing osteoporosis in this patient?
a. AA ethnicity
b. Past smoker
c. Present use of steroids
d. Female gender
e. BMI > 30 kg/m2
4
2
, 7/18/2024
5 Question Two alendronate is prototype biphosphanate
72 y/o woman with a history of vertebral
compression fracture and a DEXA T score of -2.7 in
the left hip. What is the best initial therapy for this
patient?
A. Fosamax [Alendronate] 70 mg weekly
B. Calcitonin [1] spray to alternating nares qd
C. Prempro [estrogen / progestin] 0.625/2.5 mg [1] qd
D. Prolia [Denosumab] 60 mg SQ every 6 months
5
6 Question Two
72 y/o woman with a history of vertebral
compression fracture and a DEXA T score of -2.7 in
the left hip. What is the best initial therapy for this
patient?
A. Fosamax [Alendronate] 70 mg weekly
B. Calcitonin [1] spray to alternating nares qd
C. Prempro [estrogen / progestin] 0.625/2.5 mg [1] qd
D. Prolia [Denosumab] 60 mg SQ every 6 months
6
3
, 7/18/2024
Type text here
7 Question Three
75 y/o woman with newly diagnosed osteoporosis, being
discharged after total hip replacement due to right hip
fracture. She has never been medication for
osteoporosis. PMH is significant for severe GERD, DVT [20
years ago], atrial fibrillation and family history of breast
cancer. Which therapy may offer the MOST benefit in
this patient?
A. Prolia [Denosumab] 60 mg SQ every 6 months
B. Calcitonin [1] spray to alternative nares qd
dvt knocks this out C. Evista [Raloxifene] 60 mg daily
use forteo to stimulate
D. blast - very severe
Forteo disease20 mcg SC daily
[Teriparatide]
E. Reclast [Zoledronic acid] 5 mg IV every 12 months cont with afib
7
8 Question Three
75 y/o woman with newly diagnosed osteoporosis, being
discharged after total hip replacement due to right hip
fracture. She has never been medication for
osteoporosis. PMH is significant for severe GERD, DVT [20
years ago], atrial fibrillation and family history of breast
cancer. Which therapy may offer the MOST benefit in this
patient?
A. Prolia [Denosumab] 60 mg SQ every 6 months
B. Calcitonin [1] spray to alternative nares qd
C. Evista [Raloxifene] 60 mg daily
D. Forteo [Teriparatide] 20 mcg SC daily
E. Reclast [Zoledronic acid] 5 mg IV every 12 months
8
4
